Position in ENLV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$275
-$190 QoQ
Shares Held
33
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 25 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ENLV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Steward Partners Investment Advisory, LLC holds $58,588,979 across 162 Biotechnology names. ENLV ranks #148 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
351,178 | $13,699,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,851 | $10,357,317 | |
| 3 | ARGX |
Argenx SE
|
9,982 | $9,261,000 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,148 | $3,209,983 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
55,012 | $3,147,786 | |
| 6 | CRMD |
CorMedix Inc.
|
232,615 | $1,826,027 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
165,142 | $1,621,694 | |
| 8 | NKTR |
Nektar Therapeutics
|
18,279 | $1,276,056 |
All Filings in ENLV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $275 | 500 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $465 | 500 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $351 | 500 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,600 | 2,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,800 | 2,500 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,425 | 2,500 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,925 | 2,500 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $5,040 | 3,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,260 | 3,000 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $11,370 | 3,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,100 | 3,000 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,740 | 3,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,881 | 3,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,920 | 3,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,814 | 3,000 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $12,750 | 3,000 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $13,560 | 3,000 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $16,770 | 3,000 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $18,750 | 3,000 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $153,140 | 15,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $137,950 | 15,500 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $171,895 | 15,500 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $8,910 | 1,500 | Shares | Sole | 2020-10-30 | |
| No filing history on record for this holder in this stock. | ||||||